Triple

T20147936
Position Surface form Disambiguated ID Type / Status
Subject Air Test and Evaluation Squadron 20 E491355 entity
Predicate abbreviation P43 FINISHED
Object VX-20 — NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: VX-20 | Statement: [Air Test and Evaluation Squadron 20, abbreviation, VX-20]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: VX-20
Context triple: [Air Test and Evaluation Squadron 20, abbreviation, VX-20]
  • A. VX-24
    VX-24 is a U.S. Navy air test and evaluation squadron responsible for testing and assessing naval aircraft systems and weapons.
  • B. VX-548
    VX-548 is an investigational non-opioid pain medication developed by Vertex Pharmaceuticals that targets NaV1.8 sodium channels to treat acute and chronic pain.
  • C. VX
    VX is the IATA airline designator used for the former U.S.-based low-cost carrier Virgin America.
  • D. VX-264
    VX-264 is an investigational therapy being developed by Vertex Pharmaceuticals, likely targeting a serious disease area such as cystic fibrosis or another genetic condition within the company’s clinical pipeline.
  • E. VX-31
    VX-31 is a United States Navy air test and evaluation squadron responsible for testing and assessing the performance of naval aircraft and related systems.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: VX-20
Target entity description: VX-20 is a U.S. Navy air test and evaluation squadron responsible for testing and assessing naval aircraft and aviation systems.
  • A. VX-24
    VX-24 is a U.S. Navy air test and evaluation squadron responsible for testing and assessing naval aircraft systems and weapons.
  • B. VX-548
    VX-548 is an investigational non-opioid pain medication developed by Vertex Pharmaceuticals that targets NaV1.8 sodium channels to treat acute and chronic pain.
  • C. VX
    VX is the IATA airline designator used for the former U.S.-based low-cost carrier Virgin America.
  • D. VX-264
    VX-264 is an investigational therapy being developed by Vertex Pharmaceuticals, likely targeting a serious disease area such as cystic fibrosis or another genetic condition within the company’s clinical pipeline.
  • E. VX-31
    VX-31 is a United States Navy air test and evaluation squadron responsible for testing and assessing the performance of naval aircraft and related systems.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69da6265f8f0819080b29c752a574088 completed April 11, 2026, 3:01 p.m.
NER Named-entity recognition batch_69e667a0075c8190a5c4de53a0caa7f6 completed April 20, 2026, 5:51 p.m.
Created at: April 11, 2026, 11:33 p.m.